These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 2820312
41. A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer. Shinkai T, Eguchi K, Sasaki Y, Tamura T, Ohe Y, Kojima A, Oshita F, Saijo N. Eur J Cancer; 1991; 27(5):571-5. PubMed ID: 1647183 [Abstract] [Full Text] [Related]
42. [Effect of the pulmonary artery infusion chemotherapy of non-small cel lung cancer]. Fukuhara H, Oomura M, Sasaki H. Gan To Kagaku Ryoho; 1989 Jul; 16(7):2469-72. PubMed ID: 2546507 [No Abstract] [Full Text] [Related]
50. Comparison of cisplatin plus vindesine with cisplatin plus mitomycin C for treatment of advanced non-small-cell lung cancer. The Eastern Shikoku Lung Cancer Chemotherapy Group. Shimizu E, Ogura T, Sone S, Nakayama T, Doi H, Takishita Y, Bando H, Kobayashi M, Kimura K, Sasaki H. Oncology; 1993 Jul; 50(1):5-9. PubMed ID: 8380634 [Abstract] [Full Text] [Related]
51. [Beneficial effect of cisplatin based combination chemotherapy on adenocarcinoma of the lung]. Ueoka H, Ohnoshi T, Numata T, Kawahara S, Nishii K, Yonei T, Yamashita H, Ishii J, Moritaka T, Kiura K. Gan To Kagaku Ryoho; 1989 Nov; 16(11):3559-65. PubMed ID: 2479339 [Abstract] [Full Text] [Related]
53. A randomized trial with mitomycin-C/ifosfamide versus mitomycin-C/vindesine versus cisplatin/etoposide in advanced non-small-cell lung cancer. Gatzemeier U, Heckmayr M, Hossfeld DK, Kaukel E, Koschel G, Neuhauss R. Am J Clin Oncol; 1991 Oct; 14(5):405-11. PubMed ID: 1659174 [Abstract] [Full Text] [Related]
54. Randomized comparison of two combination regimens versus minimal chemotherapy in nonsmall-cell lung cancer: a Southeastern Cancer Study Group Trial. Luedke DW, Einhorn L, Omura GA, Sarma PR, Bartolucci AA, Birch R, Greco FA. J Clin Oncol; 1990 May; 8(5):886-91. PubMed ID: 2159054 [Abstract] [Full Text] [Related]
55. [Combination chemotherapy including cisplatin in lung cancer by bronchial artery infusion]. Tanaka N, Inoue F, Takeda I, Mori T, Miyake M, Mimura H, Orita K. Gan To Kagaku Ryoho; 1988 Jan; 15(1):59-66. PubMed ID: 2447836 [Abstract] [Full Text] [Related]
56. Phase III trial with and without lonidamine in non-small cell lung cancer. Gatzemeier U, Cavalli F, Häussinger K, Kaukel E, Koschel G, Martinelli G, Neuhauss R, von Pawel J. Semin Oncol; 1991 Apr; 18(2 Suppl 4):42-8. PubMed ID: 1851577 [Abstract] [Full Text] [Related]
57. A randomized trial fo three cisplatin-containing regimens in advanced non-small-cell lung cancer (NSCLC): a study of the Umbrian Lung Cancer Group. Crino L, Tonato M, Darwish S, Meacci ML, Corgna E, Di Costanzo F, Buzzi F, Fornari G, Santi E, Ballatori E. Cancer Chemother Pharmacol; 1990 Apr; 26(1):52-6. PubMed ID: 2157554 [Abstract] [Full Text] [Related]
59. Randomized phase II trial comparing two chemotherapy combinations for non-small cell lung cancer. Mitomycin, ifosfamide, and cisplatin versus vindesine, ifosfamide, and cisplatin. González Barón M, Artal A, Garrido P, García Girón C, Ordóñez A, Feliu J, Berrocal A, Barón JM. Am J Clin Oncol; 1993 Aug; 16(4):310-4. PubMed ID: 8392287 [Abstract] [Full Text] [Related]